1 Min Read
May 30 (Reuters) - Hedgepath Pharmaceuticals Inc:
* Hedgepath Pharmaceuticals announces granting of type-c meeting request by FDA and provides positive clinical trial update Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.